Chadwick Harman
Directeur des opérations chez BLUE WATER VENTURES INTERNATIONAL, INC.
Postes actifs de Chadwick Harman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BLUE WATER VENTURES INTERNATIONAL, INC. | Directeur/Membre du Conseil | - | - |
| Directeur des opérations | 12/12/2023 | - | |
| Directeur Général | - | 12/12/2023 | |
| President | - | 12/12/2023 | |
Psycheceutical, Inc.
 Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021. | President | 12/12/2023 | - |
Historique de carrière de Chadwick Harman
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| President | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Commercial Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BLUE WATER VENTURES INTERNATIONAL, INC. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Psycheceutical, Inc.
Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021. | Health Technology |
- Bourse
- Insiders
- Chadwick Harman
- Expérience
